Beam Therapeutics Inc
NASDAQ:BEAM
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Beam Therapeutics Inc
NASDAQ:BEAM
|
US |
|
3i Group PLC
LSE:III
|
UK |
|
E
|
Electronic Arts Inc
XMUN:ERT
|
US |
|
FINEOS Corporation Holdings PLC
F:0M9
|
IE |
|
O
|
ON Semiconductor Corp
XMUN:XS4
|
US |
|
K
|
Kroger Co
LSE:0JS2
|
US |
|
Cross Country Healthcare Inc
NASDAQ:CCRN
|
US |
|
D
|
Dominion Energy Inc
XMUN:DOD
|
US |
|
Foghorn Therapeutics Inc.
NASDAQ:FHTX
|
US |
|
Jacobs Engineering Group Inc
NYSE:J
|
US |
|
B
|
BP PLC
F:BSU
|
UK |
|
C
|
China Construction Bank Corp
F:C6T
|
CN |
|
Fortress Biotech Inc
NASDAQ:FBIO
|
US |
|
B
|
Bloom Energy Corp
F:1ZB
|
US |
|
M
|
Mitsubishi Electric Corp
XMUN:MIE1
|
JP |
|
L
|
Lindblad Expeditions Holdings Inc
F:LI4
|
US |
|
H
|
Hyundai Motor Co
LSE:HYUP
|
KR |
|
BriQ Properties REIC
F:BRW
|
GR |
|
G
|
Grupo Aeroportuario del Sureste SAB de CV
SWB:AEDA
|
MX |
|
C
|
Comtech Telecommunications Corp
XMUN:CC6
|
US |
|
D
|
Dai-ichi Life Holdings Inc
XBER:QHH
|
JP |
|
N
|
Natera Inc
F:45E
|
US |
|
A
|
Asana Inc
F:A6N
|
US |
|
John Wiley & Sons Inc
NYSE:WLY
|
US |
Bankruptcy Probability
Beam Therapeutics Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Beam Therapeutics Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
Beam Therapeutics Inc
NASDAQ:BEAM
|
3.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| JP |
|
Takara Bio Inc
TSE:4974
|
120.4T JPY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
450.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
197.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
161B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
134.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
68.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
50.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Beam Therapeutics Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Beam Therapeutics Inc has total debt of 100.2m USD. This includes both short-term (0 USD) and long-term (100.2m USD) debt.
You can find a full breakdown on its Balance Sheet.
